Study ID: TBB-COPD-20009
Study Title
- A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease
Teva Identifier
- TBB-COPD-20009
ClinicalTrials.gov Identifier
- NCT02203474
Study Status
- Withdrawn
Trial Condition(s)
- Chronic Obstructive Pulmonary Disease | COPD
Interventions
- Drug: Tiotropium HFA BAI 5 mcg | Drug: Tiotropium 18 mcg Capsule | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 40 Years to 80 Years
Trial Duration
- 08/01/2014 - 08/01/2014
Phase
- Phase 2
Study Type
Interventional
